- Home
- ACON vs HSDT Comparison
ACON vs HSDT Comparison
Compare ACON & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- HSDT
- Stock Information
- Founded
- ACON 2008
- HSDT 2014
- Country
- ACON United States
- HSDT United States
- Employees
- ACON N/A
- HSDT N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACON Technology
- HSDT Health Care
- Exchange
- ACON Nasdaq
- HSDT Nasdaq
- Market Cap
- ACON 1.7M
- HSDT 1.8M
- IPO Year
- ACON 2022
- HSDT N/A
- Fundamental
- Price
- ACON $0.17
- HSDT $0.45
- Analyst Decision
- ACON Strong Buy
- HSDT Buy
- Analyst Count
- ACON 1
- HSDT 2
- Target Price
- ACON $1.50
- HSDT $24.00
- AVG Volume (30 Days)
- ACON 748.9K
- HSDT 116.7K
- Earning Date
- ACON 11-14-2024
- HSDT 11-12-2024
- Dividend Yield
- ACON N/A
- HSDT N/A
- EPS Growth
- ACON N/A
- HSDT N/A
- EPS
- ACON N/A
- HSDT N/A
- Revenue
- ACON $49,289.00
- HSDT $502,000.00
- Revenue This Year
- ACON N/A
- HSDT $16.41
- Revenue Next Year
- ACON $256.16
- HSDT $31.97
- P/E Ratio
- ACON N/A
- HSDT N/A
- Revenue Growth
- ACON N/A
- HSDT N/A
- 52 Week Low
- ACON $0.16
- HSDT $0.37
- 52 Week High
- ACON $7.39
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- ACON 41.09
- HSDT 39.76
- Support Level
- ACON $0.16
- HSDT $0.44
- Resistance Level
- ACON $0.21
- HSDT $0.58
- Average True Range (ATR)
- ACON 0.02
- HSDT 0.06
- MACD
- ACON -0.00
- HSDT 0.00
- Stochastic Oscillator
- ACON 10.42
- HSDT 4.17
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.